UNGA 2024 and the AMR HLM:
Reports released in preparation
During the run-up to the HLM (High-Level Meeting) on AMR during UNGA 2024 (the UN General Assembly, September 2024, see the 15 Apr 2023 newsletter for details), I thought it would be useful to have a list of major reports that had been released to inform those discussions. I am sure I am going to miss things (at least initially), so please drop me a note (john.rex@amr.solutions) if you want to see something added to this list. Thanks, —jr
- Reports (mostly) Focused on AMR related to human health
- Manufacturing
- 05 Jun 2023: Antibiotic Manufacturing Certification
- The AMR Industry Alliance has worked with BSI Standards to develop a certification process for safe discharge during antibiotic manufacturing.
- Press release, website, 25 Sep 2023 newsletter
- 05 Jun 2023: Antibiotic Manufacturing Certification
- Stewardship and Access
- 22 Mar 2021: Stewardship & Access Guide
- From CARB-X, Wellcome, And Partners, this is the definitive guide
- The 22 Mar 2021 newsletter is the best starting point; it also includes a video chat about the new guidelines
- Feb 2024: Equitable & Responsible Access Roadmap
- The AMR Industry Alliance‘s roadmap covers diagnostics, drugs, and procurement.
- The document itself
- 22 Mar 2021: Stewardship & Access Guide
- R&D: Push, Pull, and People
- 07 Sep 2023: Overcoming Resistance
- This one could have been subtitled “How Canada should Pull for new antibiotics”!
- Webpage, report, one-pager on the report, short slide deck, and 8 Sep 2023 newsletter.
- Report author: Canadian Council of Academies (CCA)
- 21 Sep 2023: A New Grand Bargain to Improve the Antimicrobial Market for Human Health
- Tackles the question of “Why would any given group take action to support an antibiotic ecosystem?” from the perspective of High-Income Countries (HICs), Low- and Middle-Income Countries (LMICs), Pharmaceutical companies, and International Organizations.
- Webpage, report, and 5 Nov 2023 newsletter.
- Report author: Center for Global Development (CGD)
- 15 Nov 2023: Value and sustainability of antibiotics as essential tools for the healthcare system and people’s health
- This one could have been subtitled “How Italy should Push and Pull as it takes the 2024 G7 chair“!
- Webpage, full report (in Italian), press release (in English), one-page policy brief (in English), and 7 Dec 2023 newsletter.
- Report author: The European House – Ambrosetti
- 08 Feb 2014: Leaving the Lab: Tracking the Decline in AMR R&D Professionals
- As you can infer from this title, this one summarizes the alarming multi-year decline in the number of active AMR R&D professionals.
- Press release, report, and 8 Feb 2024 newsletter.
- 15 Feb 2024: 2024 AMR Preparedness Index Progress Report
- Updates a 2021 survey on progress on National Action Plans, Push-Pull, Access, Appropriate Use, and Environmental Protection by 11 countries (Brazil, Canada, China, France, Germany, India, Italy, Japan, South Korea, UK, US).
- Press release, report, and 15 Feb 2024 newsletter.
- Report authors: Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA)
- 22 Feb 2024: The Economics of Antibiotic Resistance
- A superb tour of way an economist (and hence a Finance Minister) would view AMR as a Market Failure
- Webpage, paper, blog, and 28 Feb 2024 newsletter
- Report authors: For the Center for Global Development (CGD), Anthony McDonnell, Ranil Dissanayake, Katherine Klemperer, Flavio Toxvaerd, and Michael Sharland
- 25 Mar 2024: Effective antibiotics for the Swiss health care system: today and in the future
- This one could have been subtitled “How Switzerland should Push and Pull“!
- Webpage, primary report, and 5 April 2024 newsletter
- Report author: Swiss Roundtable on Antibiotics
- 3 Apr 2024: Towards Specific Commitments and Action in the Response to Antimicrobial Resistance
- Yes, it’s a long title! And, there is a subtitle: Recommendations for consideration by UN Member States in the outcome document of the High-level Meeting on AMR in September 2024
- Webpage, report, and 19 Apr 2024 newsletter
- There is also an important economic study that is used as supportive evidence. It is hard to find, but I do have this link: https://www.amrleaders.org/resources/m/item/annex-to-the-glg-report
- Report author: GLG AMR (Global Leaders Group on Antimicrobial Resistance)
- 07 Sep 2023: Overcoming Resistance
- Reports (mostly) focused on agriculture and food chain
- January 2024: Tackling Antimicrobial Resistance in Food and Agriculture
- A global survey of actions being taken by the Quadripartite, the Global Leaders Group, and the various National Action Plans on AMR in agricultural and food systems.
- Webpage, report, and 27 Jan 2024 newsletter.
- Report author: FAO
- About the AMR HLM (High-Level Meeting)
- 23 Jan 2024: Resolution to support an HLM on AMR
- 2 Feb 2024: Letter from the President of the General Assembly announcing the HLM
During the run-up to UNGA 2024 and the HLM on AMR (15 Apr 2023 newsletter for details), I thought it would be useful to have a list of major reports. I am sure I am going to miss things (at least initially), so please drop me a note (john.rex@amr.solutions) if you want to see something added to this list.
Share
New UK 5-year AMR plan: Subscription model details!
Dear All, Today is a newsletter double-header! Coming hard on the heels of the opportunity to support an ESCMID petition to UNGA 2024, the UK today released the details of its next five-year action plan. Excitingly for this audience, there is an updated roadmap for the UK’s next steps in its subscription model. Here are
ESCMID’s UNGA 2024 Petition to EU Health Ministers: Sign and Send!
Dear All, During the GLG AMR (Global Leaders Group for AMR) event just before ECCMID (see the 3 May 2024 newsletter entitled “Path To UNGA 2024 As Of 3 May 24 / Events On 14-15 May (DC, NYC)” for details), ESCMID leadership announced that ESCMID had developed a petition to be sent by and from the
Path to UNGA 2024 as of 3 May 24 / Events on 14-15 May (DC, NYC)
Dear All, Well, ECCMID 2024 (Barcelona) has come and gone. I saw many of you there … but it’s always so busy … and the conference center was simply enormous! Could not keep up. But, it was great to get the sense that we’re back as a community … very good attendance. The one thing
R&D Implications: Global Burden Disease is 28% Infectious!
Dear All (with thanks to Erin Duffy for co-authoring and with a wonkish alert! Refresh your coffee!), In a fascinating follow-up to their 2022 paper on the global burden of antimicrobial resistance (20 Jan 2022 newsletter entitled “#AMRSOS! GRAM Report: ‘At Least 1.27m Deaths/Year Directly Attributable To AMR’”), the team at IHME (Institute for Health